Conference Coverage

Common infections are potent risk factor for MI, stroke


 

REPORTING FROM ACC 2018


He sees the ACALM findings as hypothesis generating, serving to help lay the groundwork for future clinical trials of vaccine or anti-inflammatory antibiotic therapies.

Dr. Carter reported having no financial conflicts related to his presentation.

SOURCE: Carter P. ACC 2018, Abstract 1325M-0.

Pages

Recommended Reading

Abstract: Impact of the Commercialization of Three Generic Angiotensin II Receptor Blockers on Adverse Events in Quebec, Canada
Clinician Reviews
VIDEO: No short-term link found between PPIs, myocardial infarction
Clinician Reviews
When “Different” Is Not OK
Clinician Reviews
A Test in Context: Lipid Profile, Fasting Versus Nonfasting
Clinician Reviews
Abstract: Electrocardiograms in Low-Risk Patients Undergoing an Annual Health Examination
Clinician Reviews
Higher preconception blood pressure linked to pregnancy loss
Clinician Reviews
This Evaluation Is a Heart-stopper
Clinician Reviews
Cardiovascular risk in type 2 diabetes: Patients are often clueless
Clinician Reviews
EAGLES: Smoking cessation therapy did not up cardiovascular risk
Clinician Reviews
Abstract: Coronary Computed Tomography Angiography vs Functional Stress Testing for Patients With Suspected Coronary Artery Disease: A Systematic Review and Meta-analysis
Clinician Reviews